Amerisourcebergen Corp
F:ABG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
214.6
327.1
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one ABG stock under the Base Case scenario is 434.12 EUR. Compared to the current market price of 295.05 EUR, Amerisourcebergen Corp is Undervalued by 32%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Amerisourcebergen Corp.
| US |
|
Mckesson Corp
NYSE:MCK
|
|
| US |
|
Cencora Inc
NYSE:COR
|
|
| US |
|
Cardinal Health Inc
NYSE:CAH
|
|
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
|
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
|
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
|
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
|
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
|
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
|
| AU |
E
|
EBOS Group Ltd
OTC:EBOSY
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
The ongoing litigation and regulatory scrutiny surrounding the opioid crisis pose material financial and reputational risks, potentially leading to hefty settlements and stricter distribution requirements that could compress margins.
Shrinking margins in the pharmaceutical wholesale industry, driven by aggressive pricing negotiations from large healthcare providers and rising competition from other distributors, may curb AmerisourceBergen’s profitability despite continued volume growth.
Any reduced dependence on wholesale distributors by major pharmacy chains, compounded by the threat of new digital entrants aiming to bypass traditional distribution channels, could cut into AmerisourceBergen’s core revenue streams.
AmerisourceBergen’s deep-rooted partnerships, such as those with Walgreens Boots Alliance, grant the firm a scale advantage that helps lock in large distribution contracts and fortify its competitive position.
Strategic focus on specialty pharmaceuticals—particularly oncology and biosimilars—positions AmerisourceBergen to benefit from growing demand in complex therapies and advanced medications, supporting higher margins than traditional generics.
Investment in global reach through acquisitions and expansion into emerging markets bolsters the company’s ability to capture cross-border opportunities and further diversify its revenue base.
Revenue & Expenses Breakdown
Amerisourcebergen Corp
Balance Sheet Decomposition
Amerisourcebergen Corp
| Current Assets | 52.2B |
| Cash & Short-Term Investments | 4.4B |
| Receivables | 26.9B |
| Other Current Assets | 21B |
| Non-Current Assets | 24.4B |
| PP&E | 2.5B |
| Intangibles | 17.5B |
| Other Non-Current Assets | 4.4B |
| Current Liabilities | 57.8B |
| Accounts Payable | 54.7B |
| Accrued Liabilities | 3B |
| Other Current Liabilities | 117.8m |
| Non-Current Liabilities | 17.3B |
| Long-Term Debt | 7.5B |
| Other Non-Current Liabilities | 9.7B |
Free Cash Flow Analysis
Amerisourcebergen Corp
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Amerisourcebergen Corp
|
Revenue
|
321.3B
USD
|
|
Cost of Revenue
|
-310B
USD
|
|
Gross Profit
|
11.3B
USD
|
|
Operating Expenses
|
-7.5B
USD
|
|
Operating Income
|
3.7B
USD
|
|
Other Expenses
|
-2.2B
USD
|
|
Net Income
|
1.6B
USD
|
ABG Profitability Score
Profitability Due Diligence
Amerisourcebergen Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
Score
Amerisourcebergen Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.
ABG Solvency Score
Solvency Due Diligence
Amerisourcebergen Corp's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Amerisourcebergen Corp's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ABG Price Targets Summary
Amerisourcebergen Corp
According to Wall Street analysts, the average 1-year price target for ABG is 329.83 EUR with a low forecast of 237.83 EUR and a high forecast of 369.27 EUR.
Dividends
Current shareholder yield for 0HF3 is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one ABG stock under the Base Case scenario is 434.12 EUR.
Compared to the current market price of 295.05 EUR, Amerisourcebergen Corp is Undervalued by 32%.